GSK-3 inhibitor treatment effect on MLL leukemia cell
Source: NCBI BioProject (ID PRJNA122197)

0 0

Project name: Homo sapiens
Description: Human leukemia cell line RS4.11 was treated with GSK-3 inhibitor SB216763 for 20 hours. Gene expression profiling was performed to analyze genes affected by GSK-3 inhibition.Overall design: Human leukemia cell line RS4.11 was grown in vitro and treated with 10 uM GSK-3 inhibitor SB216763 or solvent DMSO for 20 hours. Total RNA was extracted and microarray analysis was performed. Two controls and three inhibitor treatment samples were analyzed.
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: Pathology, Stanford University
Literatures
  1. PMID: 20541704
Last updated: 2010-01-04